Experienced Post-Market Surveillance quality leader specializing in complaint handling, global vigilance, and regulatory compliance. Guides safety and reporting decisions for high-risk complaints while improving cycle times and ensuring timely, compliant submissions. Utilizes data-driven insights and cross-functional collaboration to enhance product safety and quality systems.
Overview
18
18
years of professional experience
Work History
Manager, Regulatory Affairs
West Pharmaceutical Services
Exton, PA
10.2022 - 09.2025
Led regulatory intelligence and signal detection efforts, identifying safety trends such as [specific safety trends] prior to market impact and advising stakeholders on clinical and regulatory risk mitigation strategies.
Conducted clinical safety evaluations, risk assessments, and predictive trend analyses to proactively mitigate [Number] emerging health risks, resulting in a [Percentage]% decrease in adverse events and strengthening regulatory decision making.
Conducted gap assessments to identify deficiencies in submission documentation, enhancing compliance with FDA/ICH requirements.
Proactively tracked and managed regulatory commitments, submission timelines, and inspection readiness activities using RIMS, facilitating timely submissions.
Authored and reviewed regulatory documentation, including PMSR and PSURs, contributing to zero audit findings and leading a high-performing regulatory team to maintain regulatory and quality standards.
Led global cross-functional initiatives to optimize complaint management processes, reducing backlog by over 90% within six months, and implemented harmonized Post-Market Surveillance (PMS) procedures, ensuring consistent regulatory compliance.
Manager, Post-Market Surveillance
Apex Medical Corporation
Clearwater, FL
04.2021 - 10.2022
Conducted clinical evaluations and post-market analysis, leveraging adverse event trends to drive risk mitigation and reduce field complaints by 35%.
Managed post-market complaints and regulatory reporting, achieving 100% on-time global vigilance submissions.
Monitored global signal detection and regulatory intelligence, advising stakeholders on clinical and compliance risks to guide strategic decisions.
Collaborated with cross-functional teams during FDA inspections and regulatory audits, resulting in zero observations.
Developed and mentored high-performing PMS team, improving operational efficiency and maintaining adherence to regulatory timelines.
Complaints Supervisor
Getinge (formerly Magnet)
Wayne, NJ
05.2019 - 04.2021
Led global complaint operations, reducing backlog 90% through workflow optimization.
Analyzed complaint trends; collaborated with Regulatory, Quality, Engineering teams to enhance post-market compliance and drive continuous improvement initiatives.
Assessed product/process changes for regulatory impact; coordinated cross-functional approvals through electronic change management systems to ensure compliance.
Delivered medical device vigilance training to enhance regulatory compliance and support successful inspections.
Managed team of 15, achieving 128% of annual business objectives, and improving operational performance and KPIs.
Medical Complaints Analyst
Diagnostics Stage Inc.
Parsippany, NJ
01.2017 - 05.2019
Oversaw end-to-end complaint lifecycle, achieving 100% compliance with ISO 13485:2016 and FDA QMSR.
Managed 500+ annual IVD product complaints, ensuring adherence to FDA regulations and ISO standards, safeguarding product safety.
Conducted investigations and risk assessments to assess product safety and identify measures to mitigate potential health hazards.
Collaborated with Quality and Clinical teams on root cause investigations, achieving 100% on-time MDR and vigilance submissions.
Quality Complaint RN
Lifebelt Corporation
Branchburg, NJ
11.2015 - 12.2016
Evaluated complex donor and clinical records to determine medical suitability for Human Cells, Tissues, and Cellular and Tissue-Based Product donation, achieving 100% compliance with FDA 21 CFR Part 1271 and AATB standards while mitigating biohazard and contamination risks.
Directed root cause investigations for high-risk tissue and graft complaints, conducting Health Hazard Evaluations (HHE) to ensure 100% compliance with FDA 21 CFR Part 1271 and AATB standards.
Applied clinical expertise in MDR and Vigilance assessments for IVD portfolios, ensuring 100% compliance with FDA QMSR, ISO 13485, and 21 CFR 803.
Registered Nurse/Charge Nurse
Saint Barnabas Medical Center
Livingston, NJ
05.2007 - 11.2015
Delivered peri-operative care in high-acuity environments, ensuring adherence to departmental SOPs, TJC standards, and infection control protocols to enhance patient safety across all phases of surgical care.
Guided clinical escalation during high-acuity cases, reinforcing adherence to surgical safety protocols and supporting staff decision-making to mitigate risks.
Managed daily unit operations as Charge Nurse, overseeing resource allocation and risk mitigation strategies to sustain compliance with patient safety benchmarks and optimize surgical flow.
FDA Medical Device Regulations (21 CFR 803, 806, 820)
EU Medical Device Regulations (EU MDR, MDCG, MEDDEV)
CAPA Management & Root Cause Investigation
Trend Analysis & Quality Reporting
Team Leadership & Development
Cross-functional Leadership
Gap Analysis & Process Standardization
Professional Highlights
Global Compliance Strategy: Reduced complaint backlog by 90%+ and harmonized post-market surveillance processes with FDA QMSR and EU IVDR requirements.
Clinical Risk Oversight: Led Health Hazard Evaluations (HHEs) and advanced trend analysis to proactively mitigate patient safety risks and support regulatory decision-making.
Audit Readiness: Achieved zero findings across 5+ FDA and Notified Body inspections through sustained inspection readiness and robust quality systems.
Organizational Scaling: Built and scaled global Quality and Regulatory teams, surpassing performance targets by 128% while strengthening engagement and accountability.